Latest Listings And Ipos News

Resource Development Group Limited has been suspended from ASX trading following the appointment of voluntary administrators, reflecting serious financial distress and regulatory breaches.

Terrain Minerals has completed an expanded 22-hole drilling campaign at its Smokebush Gold Project and is progressing metallurgical studies at Larin’s Lane Gallium/REE project, backed by a recent $1.58 million capital raise.

Anatara Lifesciences has received nearly $1 million from the Australian Government’s R&D tax incentive, providing a vital capital injection to advance its Anti-Obesity pre-clinical studies.

Peninsula Energy has completed a major reset of its uranium offtake contracts, terminating five of six agreements with a $6.6 million payout, while advancing commissioning of its Central Processing Plant toward first yellowcake production in Q3 2025.

Elsight Limited has responded to ASX concerns over a premature media report on its $60 million capital raise, denying any unauthorized disclosures and reaffirming its compliance with continuous disclosure rules.

Norfolk Metals has successfully raised $3.5 million in an oversubscribed placement to fund its maiden drilling program at the Carmen Copper Project in Chile, signaling strong investor confidence and a clear path toward resource definition.

Tivan Limited has taken significant strides in financing its Speewah Fluorite Project, securing a conditional Letter of Support from Export Finance Australia and moving into the Northern Australia Infrastructure Facility’s due diligence phase. These developments mark important progress toward full project funding and highlight fluorite’s rising strategic importance.

Delta Lithium has completed the demerger and IPO of its Mt Ida Gold asset into Ballard Mining, raising $30 million and retaining a 46% stake, while significantly expanding its lithium project tenure in Western Australia.

Global Lithium Resources has made significant progress on its Manna Lithium Project, advancing its Definitive Feasibility Study and securing a key variation to its offtake agreement with Canmax. The company also reported a substantial reduction in its cash burn rate, maintaining a strong cash position.

NEXION Group has completed the sale of its data centre subsidiary to Carrier Connect for AUD 2.5 million, marking a strategic shift to sharpen its focus on core network and AI software businesses.

Radiopharm Theranostics has received FDA clearance to begin a Phase I clinical trial for RV-01, a novel radiopharmaceutical targeting the 4Ig isoform of B7-H3 in solid tumors, marking a significant step forward in cancer treatment innovation.

Jcurve Solutions has raised $1 million through a strategic share placement at a significant premium, bringing on a new investor with deep Oracle NetSuite expertise and appointing a nominee director to its board.